Literature DB >> 7937056

Antithrombin III: summary of first database update.

D A Lane1, R J Olds, S L Thein.   

Abstract

Antithrombin III is the most important inhibitor of coagulation proteinases such as thrombin and factor Xa. Inherited deficiency of antithrombin III is a well recognised risk factor for the early development of venous thromboembolism. The gene for antithrombin III is located at chromosome 1q 23-25 and its structural organisation has been described. A database of mutations of the antithrombin III gene has been compiled and a recent update lists 184 entries. These entries are listed according to subtype of deficiency and to nucleotide sequence number. There are 68 reports of type I 'classical' and 116 reports of type II 'variant' deficiencies. This summary considers the entries in terms of the number of unique molecular events, the nature of the genetic defects and the role of CpG dinucleotides in deficiency. Sample listings of type I and II deficiency entries are provided.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937056      PMCID: PMC308318     

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

Review 2.  The molecular genetics of antithrombin deficiency.

Authors:  R J Olds; D A Lane; S L Thein
Journal:  Br J Haematol       Date:  1994-06       Impact factor: 6.998

Review 3.  Antithrombin III deficiency and thromboembolism.

Authors:  E Thaler; K Lechner
Journal:  Clin Haematol       Date:  1981-06

4.  The site in human antithrombin for functional proteolytic cleavage by human thrombin.

Authors:  I Björk; A Danielsson; J W Fenton
Journal:  FEBS Lett       Date:  1981-04-20       Impact factor: 4.124

5.  Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III gene.

Authors:  S C Bock; J F Harris; C E Schwartz; J H Ward; E J Hershgold; M H Skolnick
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

Review 6.  Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants.

Authors:  M B Hultin; J McKay; U Abildgaard
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

7.  The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.

Authors:  I Björk; C M Jackson; H Jörnvall; K K Lavine; K Nordling; W J Salsgiver
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

8.  Hereditary antithrombin III deficiency: biochemical aspects.

Authors:  G Sas
Journal:  Haematologia (Budap)       Date:  1984

9.  Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow.

Authors:  H Erdjument; D A Lane; M Panico; V Di Marzo; H R Morris
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

10.  Antithrombin-III Denver, a reactive site variant.

Authors:  A W Stephens; B S Thalley; C H Hirs
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

View more
  2 in total

Review 1.  The genetics of venous and arterial thromboembolism.

Authors:  D Lillicrap
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

Review 2.  Update of the human and mouse SERPIN gene superfamily.

Authors:  Claire Heit; Brian C Jackson; Monica McAndrews; Mathew W Wright; David C Thompson; Gary A Silverman; Daniel W Nebert; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2013-10-30       Impact factor: 4.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.